Geode Capital Management’s Park Ha Biological Technology Co BYAH Stock Holding History

Geode Capital Management’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-42	Closed	-$2.68K	–	4614
2025 Q4	$2.68K	Hold	42	–	–	﹤0.01%	4465
2025 Q3	$8.06K	Hold	42	–	–	﹤0.01%	4455
2025 Q2	$590K	Hold	42	–	–	﹤0.01%	3499
2025 Q1	$222K	Buy	+42	New	+$114K	﹤0.01%	3808

Other funds holding BYAH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's BYAH Position: Q1 2026 in Review

Geode Capital Management sold out of Park Ha Biological Technology Co (BYAH) in Q1 2026, closing a stake of 42 shares — an estimated $2.68K sold.

Geode Capital Management first reported a position in BYAH in Q1 2025 and held it in 4 quarters. The position peaked at $590K in Q2 2025. 2 funds tracked by Wall St. Rank hold BYAH as of Q1 2026.

Geode Capital Management reported no remaining Park Ha Biological Technology Co position as of Q1 2026 after selling out during the quarter.
Geode Capital Management sold 42 Park Ha Biological Technology Co shares in Q1 2026, an estimated $2.68K.
Geode Capital Management first reported a position in Park Ha Biological Technology Co in Q1 2025 and held it in 4 quarters.
Geode Capital Management's Park Ha Biological Technology Co position peaked at $590K in Q2 2025.
2 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.